---
title: "Insulet Corp. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285622196.md"
description: "Insulet Corp. (PODD) shares rose 6.03% to $160.40 on a weak trading day for the market, with the S&P 500 down 0.38% and the Dow Jones down 0.63%. This increase ended a three-day losing streak, although the stock remains 54.80% below its 52-week high of $354.88. Insulet outperformed competitors like Eli Lilly, which fell 1.22%, and Johnson & Johnson, which dropped 0.94%. Trading volume reached 2.8 million, surpassing the 50-day average of 1.1 million."
datetime: "2026-05-07T21:17:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285622196.md)
  - [en](https://longbridge.com/en/news/285622196.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285622196.md)
---

# Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Insulet Corp. (PODD) advanced 6.03% to $160.40 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.38% to 7,337.11 and Dow Jones Industrial Average falling 0.63% to 49,596.97.

The stock's rise snapped a three-day losing streak.

Insulet Corp. closed 54.80% short of its 52-week high of $354.88, which the company reached on November 20th.

The stock outperformed some of its competitors Thursday, as Eli Lilly & Co. (LLY) fell 1.22% to $974.96, DexCom Inc. (DXCM) rose 0.91% to $60.91, and Johnson & Johnson (JNJ) fell 0.94% to $222.51.

Trading volume (2.8 M) eclipsed its 50-day average volume of 1.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 7, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-07-26 1717ET

### Related Stocks

- [PODD.US](https://longbridge.com/en/quote/PODD.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)

## Related News & Research

- [A Look At Insulet (PODD) Valuation After Strong Q1 Results And Raised Revenue Guidance](https://longbridge.com/en/news/286451912.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [GRI Bio Highlights Promising Phase 2a IPF Data, Outlook](https://longbridge.com/en/news/286422240.md)